ArticleFrontiers in psychology2026

High-efficacy serum biomarkers PCSK9 and LCAT predict cognitive impairment in Parkinson's disease.

Mingyu Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.